✦ LIBER ✦

Cytokine gene transcription in renal cell carcinoma

✍ Scribed by Dr. L. Filgueira; M. Zuber; A. Merlo; V. Caetano; E. Schultz; F. Harder; G. C. Spagnoli; M. Heberer

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 474 KB
Volume: 80
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800801034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal cell carcinoma in pregnancy

✍ Janet L. Walker; Emerson L. Knight 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

Cytokine secretion associated with the c

Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients

✍ Attilio Bondanza; Patrizia Rovere; Anna Borri; Elena Rota Caremoli; Anna Guidett 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 2 views

Functional polymorphisms in cell death p

Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma

✍ Jian Zhu; Chao Qin; Meilin Wang; Fu Yan; Xiaobing Ju; Xiaoxin Meng; Qi Ding; Pu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract The FAS/FAS ligand (FASL) system plays a key role in regulating apoptotic cell death, and corruption of this signaling pathway has been shown to participate in tumorigenesis. However, the effects of functional promoter polymorphisms of the __CASP8__, __FAS__, and __FASL__ genes on risk

Targeting mTOR in renal cell carcinoma

✍ Gary R. Hudes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

Sequential therapy in renal cell carcino

Sequential therapy in renal cell carcinoma

✍ Bernard Escudier; Marine Gross Goupil; Christophe Massard; Karim Fizazi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Telomerase activity in renal cell carcin

Telomerase activity in renal cell carcinoma

✍ Ken-ichiro Yoshida; Shu-ichi Sakamoto; Shuhei Sumi; Yotsuo Higashi; Satoshi Kita 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## BACKGROUND. Telomerase activity has been shown to be increased in numerous tumors and cell lines, although to the authors' knowledge there has been no previous assessment of telomerase activity in renal cell carcinoma (RCC). To examine whether telomerase activity could be used as a biochemical p